J&J’s lung cancer therapy succeeds in head-to-head study with AstraZeneca’s drug – ET HealthWorld | Pharma
Bengaluru: Johnson & Johnson said its cancer drug combination increased the time patients with a type of non small-cell lung…
Fast News Hear
Bengaluru: Johnson & Johnson said its cancer drug combination increased the time patients with a type of non small-cell lung…
Mumbai: Johnson & Johnson Private Limited announced the appointment of Anuj Virmani as the Managing Director for its Johnson &…
Nine countries in East Europe and Central Asia with high burden of drug-resistant TB are excluded from this deal. NEW…
Private equity firm Warburg Pincus is in advanced talks to acquire Chennai-based medical equipment manufacturer Appasamy Associates, said people aware…
New Delhi: Johnson & Johnson on Wednesday faced the first trial in almost two years over claims that asbestos in…
New Delhi: The combination of AstraZeneca‘s cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer…
Bengaluru: Johnson & Johnson‘s consumer health spinoff Kenvue Inc rose 16 per cent and fetched a valuation of about $48…
New Delhi: Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the…
New Delhi: Abbott Laboratories reported quarterly profit above expectations on Wednesday, underpinned by sales of its diabetes care devices and…
By Dietrich Knauth – A Johnson & Johnson subsidiary is again asking a U.S. judge to pause tens of thousands…